Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade

Journal: Nature Communications

Published: 2018-04-18

DOI: 10.1038/s41467-018-04004-2

Affiliations: 7

Authors: 15

Go to article
Institutions FC
Division of Translational Cell Genetics, MUI, Austria 0.33
Tyrolean Cancer Research Institute (TCRI), Austria 0.23
Division of Bioinformatics, MUI, Austria 0.20
Leibniz Research Center Borstel - Center for Medicine and Biosciences (FZB), Germany 0.07
University Medical Center Schleswig-Holstein - Campus Lübeck (UKSH Lübeck), Germany 0.07
Institut für Pathologie, UB, Switzerland 0.07
University Hospital Bonn (UKB), Uni Bonn, Germany 0.03